Product Details
Naprosyn E
Naproxen375 mg
Enteric Coated Tablet
DIN/PIN/NPN
02162415
Manufacturer
Hoffmann-La Roche Limited
Formulary Listing Date
2008-01-15
Unit Price
NA
Amount MOH Pays
NA
Coverage Status
Off-Formulary Interchangeable
ODB Formulary Therapeutic Classification
Therapeutic Note
Naproxen 375 mg Enteric-Coated Tablet: NSAIDs have a high rate of serious adverse effects in the elderly. When prescribing NSAIDs, the minimal effective dose for the shortest period of time should be used. In nonspecific pain and/or osteoarthritis, in the absence of joint inflammation (swelling), acetaminophen is a better first choice for analgesia. The most effective treatment to prevent NSAID-gastritis is misoprostol; although H-2 antagonists, such as ranitidine or cimetidine, are commonly used, they are not as effective. NSAIDs can significantly aggravate hypertension and congestive heart failure; ASA in doses below 1 gram per day is a better choice than other NSAID options if anti-inflammatory effects are required in patients with these conditions. Low dose ASA has additional benefits for anti-platelet indications that are not provided by other NSAIDs, and should be given in preference or in addition to other NSAIDs for patients with vascular indications.
ATC Code
M01AE02
Interchangeable Products
DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
---|---|---|---|
02243313 | Teva-Naproxen EC | 0.3675 | NA |
02294702 | PMS-Naproxen EC | 0.3675 | NA |
02350793 | Naproxen EC | 0.3675 | NA |
02162415 | Naprosyn E | NA | NA |
02246700 | Apo-Naproxen EC | 0.3675 | NA |